Cargando…

Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet

Detalles Bibliográficos
Autores principales:	Tashkin, Donald P., Barjaktarevic, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449069/ https://www.ncbi.nlm.nih.gov/pubmed/37311252 http://dx.doi.org/10.1164/rccm.202303-0404LE

Ejemplares similares

Sleep, the Forgotten, Yet Potentially Modifiable, Dimension in Chronic Obstructive Pulmonary Disease Care
por: Stewart, Nancy H., et al.
Publicado: (2023)

Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis
por: Toppen, William, et al.
Publicado: (2022)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
por: Tashkin, Donald P
Publicado: (2020)

Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
por: Park, Seon-Cheol, et al.
Publicado: (2022)

Defining Disease Modification in Chronic Obstructive Pulmonary Disease
por: Halpin, David M.G., et al.
Publicado: (2009)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

Chronic Marijuana Use Is Associated with Gene Expression Changes in BAL
por: Liu, Cuining, et al.
Publicado: (2022)

Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later Life
por: Tashkin, Donald P.
Publicado: (2023)

How Differential Are the Effects of Smoking Cannabis versus Tobacco on Lung Function?
por: Tashkin, Donald P., et al.
Publicado: (2022)

The use of nebulized pharmacotherapies during the COVID-19 pandemic
por: Sethi, Sanjay, et al.
Publicado: (2020)

Are Rural Residence and Poverty Independent Risk Factors for Chronic Obstructive Pulmonary Disease in the United States?
por: Wei, Ran
Publicado: (2019)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
por: Tashkin, Donald P, et al.
Publicado: (2010)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012)

Reply to Wei: Are Rural Residence and Poverty Independent Risk Factors for Chronic Obstructive Pulmonary Disease in the United States?
por: Raju, Sarath, et al.
Publicado: (2019)

Biomarkers of Right Ventricular–Pulmonary Coupling in Chronic Obstructive Pulmonary Disease
por: Mehmood, Muddassir
Publicado: (2019)

Ultrasonography in Chronic Obstructive Pulmonary Disease: Fact or Fiction?
por: Alqahtani, Jaber S, et al.
Publicado: (2020)

Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Pouwels, Simon D., et al.
Publicado: (2019)

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
por: Tashkin, Donald P, et al.
Publicado: (2020)

Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Polverino, Francesca
Publicado: (2019)

Ultrasonography of diaphragm in chronic obstructive pulmonary disease: Unanswered questions
por: Hadda, Vijay, et al.
Publicado: (2020)

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021)

Health-related quality of life in chronic obstructive pulmonary disease
por: Rai, Deependra Kumar
Publicado: (2021)

Definition of Chronic Obstructive Pulmonary Disease: Occupational Environmental Contribution
por: Harber, Philip
Publicado: (2022)

Rome Criteria for Exacerbation of Chronic Obstructive Pulmonary Disease: Not Built in a Day
por: Bhatt, Surya P.
Publicado: (2022)

Malnutrition associated with readmission in elderly patients with chronic obstructive pulmonary disease
por: Zhao, Ting, et al.
Publicado: (2023)

Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs
por: Luyster, Faith S., et al.
Publicado: (2023)

Pre–Chronic Obstructive Pulmonary Disease: Toward the Limits of the Spirometric Funnel
por: Wouters, Emiel F. M.
Publicado: (2021)

Exposing Pre–Chronic Obstructive Pulmonary Disease: When Physiology Matters!
por: Neder, J. Alberto, et al.
Publicado: (2021)

Asthma with a Smoking History and Pre–Chronic Obstructive Pulmonary Disease
por: Thomson, Neil C.
Publicado: (2021)

Asthma and Chronic Obstructive Pulmonary Disease: Just Old Friends or Relatives?
por: Polverino, Francesca, et al.
Publicado: (2021)

Patients with Chronic Obstructive Pulmonary Disease Require More Than Pulmonary Rehabilitation to Improve Outcomes
por: Prieto-Centurion, Valentin, et al.
Publicado: (2019)

The poorly understood yet potent risk of pulmonary artery thrombosis in-situ in Post-Acute COVID-19 syndrome
por: Payus, Alvin Oliver, et al.
Publicado: (2023)

Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19
por: Nieri, Dario, et al.
Publicado: (2020)

Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Suriyakul, Apisara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ao4gubrenq61kmec6aggrsmn1t